Page 6 - Nasdaq Cdmo News Today

Avid Bioservices, Inc. (NASDAQ:CDMO – Get Rating) Director Richard B. Hancock sold 5,000 shares of the business’s stock in a transaction that occurred on Friday, April 1st. The stock was sold at an average price of $21.21, for a total transaction of $106,050.00. The transaction was disclosed in a filing with the Securities & Exchange […]

Shares of Avid Bioservices, Inc. (NASDAQ:CDMO – Get Rating) have been assigned an average recommendation of “Hold” from the seven ratings firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and three have assigned a buy recommendation […]

Avid Bioservices (NASDAQ:CDMO – Get Rating) announced its earnings results on Tuesday. The biopharmaceutical company reported $0.04 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.04, Fidelity Earnings reports. Avid Bioservices had a return on equity of 27.43% and a net margin of 12.13%. During the same quarter in the […]

Avid Bioservices, Inc. Announces Pricing of $125 Million Offering of Exchangeable Senior Notes March 10, 2021 00:20 ET | Source: Avid Bioservices, Inc Avid Bioservices, Inc Tustin, California, UNITED STATES TUSTIN, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP) (the “company”), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by provi...